89 related articles for article (PubMed ID: 6216489)
1. Recent observations on new potential and established antidepressant drugs.
Carlsson A
Pharmacopsychiatria; 1982 Jul; 15(4):116-20. PubMed ID: 6216489
[No Abstract] [Full Text] [Related]
2. Current theories on the mode of action of antidepressant drugs.
Carlsson A
Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723
[No Abstract] [Full Text] [Related]
3. A possible role of serotonin receptors in antidepressant drug action.
Snyder SH; Peroutka SJ
Pharmacopsychiatria; 1982 Jul; 15(4):131-4. PubMed ID: 7146092
[No Abstract] [Full Text] [Related]
4. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
[No Abstract] [Full Text] [Related]
5. History of antidepressants: successes and failures.
Kelwala S; Stanley M; Gershon S
J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
[No Abstract] [Full Text] [Related]
6. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
[No Abstract] [Full Text] [Related]
7. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
8. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of two new antidepressants.
Gershon S; Georgotas A; Newton R; Bush D
Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
[No Abstract] [Full Text] [Related]
10. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
[TBL] [Abstract][Full Text] [Related]
11. Proestrous effects of chlordecone on the serotonin system.
Williams J; Eckols K; Stewart G; Uphouse L
Neurotoxicology; 1988; 9(4):597-610. PubMed ID: 2469047
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
13. The new generation of antidepressants.
Feighner JP
J Clin Psychiatry; 1983 May; 44(5 Pt 2):49-55. PubMed ID: 6222037
[No Abstract] [Full Text] [Related]
14. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
15. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
16. [A new concept of antidepressant drugs action: clinical and preclinical data].
Płaźnik A; Kostowski W
Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
[TBL] [Abstract][Full Text] [Related]
17. Interaction of EEG sleep, antidepressants, and affective disease.
Kupfer D
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):30-6. PubMed ID: 6217197
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant mechanisms.
Goldstein S
J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142. PubMed ID: 8138512
[No Abstract] [Full Text] [Related]
19. Corticosterone response to 8-OH-DPAT after chronic administration of antidepressants.
Akiyoshi J; Nagayama H; Tsuchiyama K; Yamada K; Miyamoto T; Ito Y; Yamauchi C; Oba A; Okada K; Kojima K
Jpn J Psychiatry Neurol; 1991 Mar; 45(1):141-2. PubMed ID: 1836505
[No Abstract] [Full Text] [Related]
20. An open trial of zimelidine in patients with endogenous depression.
Kiloh LG; Moore G
Int Pharmacopsychiatry; 1982; 17(1):28-35. PubMed ID: 6211416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
